Mirum Pharmaceuticals, Inc. MIRM Operating Income
Operating Income at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s operating income?
- Mirum Pharmaceuticals, Inc. (MIRM) reported operating income of -$789.47M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s operating income changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s operating income decreased by 5099.7% year-over-year, from -$15.18M to -$789.47M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s operating income?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s operating income has grown at a -40.2% compound annual growth rate (CAGR), from -$173.41M to -$22.14M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.